Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mira A M Behnam

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Biochimie|January 23, 2021
Protein structural heterogeneity: A hypothesis for the basis of proteolytic recognition by the main protease of SARS-CoV and SARS-CoV-2Mira A M Behnam
ACS Pharmacology & Translational Science|July 15, 2022
Corona versus Dengue: Distinct Mechanisms for Inhibition of Polyprotein Processing by Antiviral DrugsMira A M Behnam, Christian D Klein
Cell Host & Microbe|December 9, 2021
On track to tackle dengue: History and future of NS4B ligandsMira A M Behnam, Christian D Klein
Biochimie|June 13, 2024
Alternate recognition by dengue protease: Proteolytic and binding assays provide functional evidence beyond an induced-fitMira A M Behnam, Christian D Klein
Biochimie|April 27, 2020
Conformational selection in the flaviviral NS2B-NS3 proteaseMira A M Behnam, Christian D P Klein
Organic Letters|April 23, 2016
Solid Phase Synthesis of C-Terminal Boronic Acid PeptidesMira A M Behnam, Tom R Sundermann, Christian D Klein
Analytical Biochemistry|September 30, 2023
2,2'-Bithiophene as sensor tag for ligand-protein binding assays based on Förster resonance energy transferMira A M Behnam, Thomas Basché, Christian D P Klein
Nature Reviews. Drug Discovery|May 6, 2017
Broad-spectrum agents for flaviviral infections: dengue, Zika and beyondVeaceslav Boldescu, Mira A M Behnam, Nikos Vasilakis, et al.
Journal of Medicinal Chemistry|January 16, 2016
The Medicinal Chemistry of Dengue VirusMira A M Behnam, Christoph Nitsche, Veaceslav Boldescu, et al.
Antiviral Research|March 7, 2012
Retro peptide-hybrids as selective inhibitors of the Dengue virus NS2B-NS3 proteaseChristoph Nitsche, Mira A M Behnam, Christian Steuer, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Biochimie|January 23, 2021
Protein structural heterogeneity: A hypothesis for the basis of proteolytic recognition by the main protease of SARS-CoV and SARS-CoV-2Mira A M Behnam
ACS Pharmacology & Translational Science|July 15, 2022
Corona versus Dengue: Distinct Mechanisms for Inhibition of Polyprotein Processing by Antiviral DrugsMira A M Behnam, Christian D Klein
Cell Host & Microbe|December 9, 2021
On track to tackle dengue: History and future of NS4B ligandsMira A M Behnam, Christian D Klein
Biochimie|June 13, 2024
Alternate recognition by dengue protease: Proteolytic and binding assays provide functional evidence beyond an induced-fitMira A M Behnam, Christian D Klein
Biochimie|April 27, 2020
Conformational selection in the flaviviral NS2B-NS3 proteaseMira A M Behnam, Christian D P Klein
Organic Letters|April 23, 2016
Solid Phase Synthesis of C-Terminal Boronic Acid PeptidesMira A M Behnam, Tom R Sundermann, Christian D Klein
Analytical Biochemistry|September 30, 2023
2,2'-Bithiophene as sensor tag for ligand-protein binding assays based on Förster resonance energy transferMira A M Behnam, Thomas Basché, Christian D P Klein
Nature Reviews. Drug Discovery|May 6, 2017
Broad-spectrum agents for flaviviral infections: dengue, Zika and beyondVeaceslav Boldescu, Mira A M Behnam, Nikos Vasilakis, et al.
Journal of Medicinal Chemistry|January 16, 2016
The Medicinal Chemistry of Dengue VirusMira A M Behnam, Christoph Nitsche, Veaceslav Boldescu, et al.
Antiviral Research|March 7, 2012
Retro peptide-hybrids as selective inhibitors of the Dengue virus NS2B-NS3 proteaseChristoph Nitsche, Mira A M Behnam, Christian Steuer, et al.
Pageof 2